The Cloud AI Engineer at Google Hyderabad/Bengaluru designs and implements GenAI and Agentic AI projects, builds data ...
Fintel reports that on November 21, 2025, Canaccord Genuity maintained coverage of HIVE Digital Technologies (NasdaqCM:HIVE) ...
HIVE Digital Technologies Ltd. (NASDAQ:HIVE) is one of the top cryptocurrency stocks to consider for long-term investment. On ...
Zacks Investment Research on MSN
HIVE Digital to Report Q2 Earnings: What's in Store for the Stock?
HIVE Digital Technologies HIVE is set to report second-quarter fiscal 2026 results on Nov. 14, 2025. The Zacks Consensus ...
Integration allows company's Beeblade units to transmit up to 16 channels of high-quality audio over Ethernet, supporting ...
Analysts expect the San Antonio, Texas-based company to report quarterly earnings at 2 cents per share, versus a year-ago ...
Novartis has claimed a first-in-class regulatory approval in the US for oral BTK inhibitor remibrutinib as a second-line treatment for chronic spontaneous urticaria (CSU), also known as chronic hives.
Hive has announced the addition of Dante networking to its Beeblade media engine range. The new integration enables Hive ...
What Is Rhapsido, and Why Does It Matter? Rhapsido (remibrutinib) is a new oral medicine approved to treat adults with chronic spontaneous urticaria (CSU). CSU is a long-term skin condition that ...
Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback